| P2093 | author name string | Serkan Unlu | |
| | Yakup Alsancak | |
| | Adnan Abaci | |
| | Burak Sezenoz | |
| | Ulker Kaya | |
| P2860 | cites work | Percutaneous closure of interatrial communications in adults - prospective embolism prevention study with two- and three-dimensional echocardiography | Q24798432 |
| | Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices | Q28167294 |
| | Percutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects | Q28188483 |
| | Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study | Q28193128 |
| | Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels? | Q28211331 |
| | Trans-catheter closure of atrial septal defect: Balloon sizing or no Balloon sizing - single centre experience | Q30475146 |
| | Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis. | Q30990633 |
| | Sustained long-term benefit of patent foramen ovale closure on migraine | Q33829743 |
| | Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migr | Q34010260 |
| | Occlusion of PFO with a dedicated adjustable device: influence on one year outcome | Q51152904 |
| | Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single-center experience. | Q51266783 |
| | Percutaneous closure of atrial septal defect type ostium secundum using the new Intrasept occluder: initial experience. | Q51286867 |
| | Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country. | Q51287785 |
| | Role of intracardiac echocardiographic guidance in transcatheter closure of atrial septal defects and patent foramen ovale using the Amplatzer device. | Q51301482 |
| | Intracardiac echocardiography guided device closure of atrial septal defects. | Q51308032 |
| | Time-course of cardiac remodeling following transcatheter closure of atrial septal defect. | Q51316421 |
| | Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry. | Q51341108 |
| | Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the Amplatzer septal occluder. | Q51360355 |
| | Percutaneous transcatheter closure of atrial septal defects: initial single-centre experience and follow-up results. Initial experience with three-dimensional echocardiography. | Q51470221 |
| | Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. | Q51506632 |
| | Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety. | Q51521310 |
| | Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. | Q51541064 |
| | Percutaneous patent foramen ovale and atrial septal defect closure in adults: results and device comparison in 100 consecutive implants at a single center. | Q51547781 |
| | Usefulness of three-dimensional echocardiographic reconstruction of the Amplatzer septal occluder in patients undergoing atrial septal closure. | Q51582291 |
| | Closure of defects of the atrial septum in adults using the Amplatzer device: 100 consecutive patients in a single center. | Q51602606 |
| | Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler. | Q51638364 |
| | Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. | Q51641017 |
| | Transthoracic echocardiographic guidance of transcatheter atrial septal defect closure. | Q51648754 |
| | New echocardiographic diameter for Amplatzer sizing in adult patients with secundum atrial septal defect: preliminary results. | Q51654720 |
| | On-line intracardiac echocardiography alone for Amplatzer Septal Occluder selection and device deployment in adult patients with atrial septal defect. | Q51671604 |
| | Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. | Q51728014 |
| | ASD Closure with the Amplatzer Device | Q51801325 |
| | Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale. | Q51834352 |
| | Transcatheter closure of very large (>or= 25 mm) atrial septal defects using the Amplatzer septal occluder. | Q51841984 |
| | Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder? | Q52913471 |
| | Pre-procedural planning for percutaneous atrial septal defect closure: Transesophageal echocardiography compared with cardiac computed tomographic angiography | Q53266551 |
| | The value of transesophageal echocardiography in transcatheter closure of atrial septal defects in the oval fossa using the Amplatzer septal occluder. | Q53326806 |
| | ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the managemen | Q55051005 |
| | Transcatheter closure of atrial septal defects using the Cardio-Seal implant | Q34012634 |
| | Incidence and predictors of atrial fibrillation following transcatheter closure of interatrial septal communications using contemporary devices | Q34026186 |
| | A European multicentric experience using the CardioSEal and Starflex double umbrella devices to close interatrial communications holes within the oval fossa | Q34069333 |
| | Closure or medical therapy for cryptogenic stroke with patent foramen ovale | Q34261237 |
| | Transcatheter device closure of atrial septal defects in patients aged 40 years and older | Q34339339 |
| | Influence of the introduction of Amplatzer device on the interventional closure of defects within the oval fossa in children | Q34452422 |
| | Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery d | Q34503740 |
| | Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients | Q35015042 |
| | Availability of percutaneous closure for an adult population with interatrial shunts. | Q35113550 |
| | Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost | Q35579942 |
| | Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children | Q35580117 |
| | Amplatzer device closure of atrial septal defects in mature adults: analysis of 76 cases | Q35582094 |
| | Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk | Q35960010 |
| | Percutaneous closure of patent foramen ovale | Q36325062 |
| | Atrial and ventricular septal defects can safely be closed by percutaneous intervention | Q36335201 |
| | Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder | Q36462389 |
| | Device closure rates of simple atrial septal defects optimized by the STARFlex device | Q36550249 |
| | Transcatheter closure of atrial septal defects in adults > or =40 years of age: immediate and follow-up results | Q36735687 |
| | Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up | Q36945917 |
| | Benefit of atrial septal defect closure in adults: impact of age. | Q36971611 |
| | Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias | Q37137078 |
| | Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect | Q37373557 |
| | The impact of transcatheter atrial septal defect closure in the older population: a prospective study. | Q39289277 |
| | Transcatheter occlusion of complex atrial septal defects | Q39426972 |
| | Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events | Q40066094 |
| | BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts | Q40276069 |
| | Patent foramen ovale using the Premere device: the results of the CLOSEUP trial | Q42693390 |
| | Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects | Q43279985 |
| | Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism | Q43418472 |
| | Early and late complications associated with transcatheter occlusion of secundum atrial septal defect | Q43526333 |
| | Midterm follow-up of percutaneous closure of secundum atrial septal defect with Helex Septal Occluder | Q43545480 |
| | Atrial septal defect closure in the elderly is associated with excellent quality of life, functional improvement, and ventricular remodelling | Q43816430 |
| | Feasibility, safety, and efficacy of real-time three-dimensional transoesophageal echocardiography for guiding device closure of interatrial communications: initial clinical experience and impact on radiation exposure | Q43968433 |
| | Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices | Q44239721 |
| | Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale. | Q44462723 |
| | Patent foramen ovale and cryptogenic stroke in older patients | Q44826276 |
| | Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO). | Q44847556 |
| | Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-up | Q44856314 |
| | Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder | Q44956156 |
| | Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke | Q45161130 |
| | Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience | Q45340260 |
| | Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device | Q45810893 |
| | A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects | Q45856883 |
| | Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. | Q45911633 |
| | Transcatheter closure of atrial septal defects with multiple devices in adults: procedural and clinical outcomes | Q46129008 |
| | Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen | Q46724278 |
| | Single centre experience with GORE-HELEX septal occluder for closure of PFO. | Q46737665 |
| | Five-year experience with percutaneous closure of patent foramen ovale | Q46811271 |
| | Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler | Q46953454 |
| | Choice of device size and results of transcatheter closure of atrial septal defect using the amplatzer septal occluder | Q47177505 |
| | Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size | Q47182925 |
| | Transcathether occlusion of interatrial communications: postprocedural transoesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation | Q47213648 |
| | Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. | Q47292094 |
| | Cardiac troponin I release after transcatheter atrial septal defect closure correlated with the ratio of the occluder size to body surface area | Q47346916 |
| | Sizing of atrial septal defects by intracardiac echocardiography for device closures | Q47364029 |
| | Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm | Q47390246 |
| | Clinical results of percutaneous closure of large secundum atrial septal defects in children using the Amplatzer septal occluder | Q47703327 |
| | Efficiency of transcatheter closure of atrial septal defects in small and symptomatic children | Q47726418 |
| | Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). | Q47751184 |
| | Device closure of large atrial septal defects requiring devices > or =20 mm in small children weighing <20 kg. | Q47823157 |
| | Balloon assessment of patent foramen ovale morphology and the modification of tunnels using a balloon detunnelisation technique | Q47859725 |
| | Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study | Q47862652 |
| | Transcatheter closure of atrial septal defects with superior-anterior rim deficiency using Amplatzer septal occluder | Q47977094 |
| | Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defects in children and adults | Q48239245 |
| | Transcatheter closure of atrial septal defects with transthoracic echocardiography | Q48298426 |
| | Transcatheter closure of atrial septal defect with Amplatzer device in children aged less than 10 years old: immediate and late follow-up | Q48550116 |
| | Transcatheter closure of patent foramen ovale in patients with cerebral ischemia | Q48568181 |
| | A noninvasive sizing method to choose fitted Amplatzer septal occluder by transthoracic echocardiography in patients with secundum atrial septal defects | Q48580450 |
| | Effectiveness of the Amplatzer device for transcatheter closure of an ostium secundum atrial septal defect | Q48592807 |
| | Real time three-dimensional transthoracic echocardiography for guiding Amplatzer septal occluder device deployment in patients with atrial septal defect | Q48660961 |
| | Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome | Q48710818 |
| | Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry | Q48865074 |
| | Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defect | Q48913028 |
| | Closure of atrial septal defects: is there still a place for surgery? | Q49098552 |
| | Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. | Q50593887 |
| | Assessment of right ventricular function by three-dimensional echocardiography and myocardial strain imaging in adult atrial septal defect before and after percutaneous closure. | Q50664215 |
| | Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. | Q50740769 |
| | Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. | Q50760448 |
| | Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. | Q50786795 |
| | Transcatheter closure of atrial septal defect without balloon sizing. | Q50870418 |
| | Closure of patent foramen ovale: when and how? | Q50871483 |
| | Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. | Q51012528 |
| | Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and long-term results. | Q51061280 |
| | Transcatheter closure of secundum atrial defect in small children. | Q51091098 |
| | Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure. | Q51104471 |
| | Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. | Q51119311 |
| | Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study. | Q51137635 |
| P433 | issue | 7 | |
| P921 | main subject | meta-analysis | Q815382 |
| | patent foramen ovale | Q3076802 |
| P304 | page(s) | 1123-1138 | |
| P577 | publication date | 2013-08-31 | |
| P1433 | published in | Catheterization and Cardiovascular Interventions | Q2352240 |
| P1476 | title | Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies | |
| P478 | volume | 82 | |